GLP1 Weight Loss Drug Costs Drive Higher CoPays Across Insurance Plans
American Graphics Signs Expands Fleet Graphics Installation Network to All 50 States
HighYield Savings Rates Reach 41 APY as of May 23 2026 What Savers Should Know
Emirates NBD Announces Open Offer for 26 Stake in RBL Bank Starting June 1
Powell Vows No Shadow Chair Role but Historic Fed Meeting with Former Chair Looms
Needham Analysts Lower Workday WDAY Price Target Amid Market Caution
Regency Centers Corporation 625 Series A Cumulative Redeemable Preferred Stock REGCP Q1 2026 Earnings Strong EPS Beat Signals Steady Preferred Dividend Coverage
BLDR Q1 2026 Earnings EPS Misses Estimates by 284 Stock Edges Higher
TEM Q1 2026 Earnings Narrower Loss Surprises Analysts but Stock Slides
Smurfit WestRock Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
BTSGU Q1 2026 Earnings EPS Surpasses Estimates by 23 Stock Flat amid Strong Operational Performance
PERF Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
Silexion Therapeutics Warrants SLXNW Hold Steady at 002 Amid Thin Trading
Maui Land Pineapple MLP Edges Higher as Support Holds Near 162
Telecom Argentina TEO Holds Steady Near 1186 as Market Awaits Catalyst
AEye Inc Warrant LIDRW Surges 10 but Holds at Key Support Analysis of Recent Activity
Elemental Royalty ELE Slips to 1669 as Bearish Momentum Persists
Lowes Signals Caution as Consumer Spending Patterns Shift
ROP Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed
Ambow Education AMBO Bounces Back Stock Rises 38 as Price Approaches Resistance
First BanCorp Q1 2026 Earnings EPS Surpasses Estimates Amid Stable Operations
American Express Q1 2026 Earnings EPS Surpasses Estimates at 428 Stock Edges Higher
Contineum Therapeutics Inc CTNM Q1 2026 Earnings Narrower Loss Beats Expectations
XTNT Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain
SCI Q1 2026 Earnings EPS Misses Estimates by 44 Shares Edge Higher
MFG Q1 2026 Earnings Strong EPS Beat of 284 as Net Interest Income Rises Yet Stock Edges Lower
GLUE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline